Chairman of the Board, Dr. Peter Schiemann, will participate at JPMorganBIO in San Francisco 12.-16. January
top of page
Search
Recent Posts
See AllPrinceton, NJ, July 6, 2023 ─ iQure Pharma Inc. (iQure), a US-based global biotech company, has been awarded a second patent for iQure-007, its novel therapeutic currently in development for the trea
59
Princeton, NJ, December 14, 2022 ─ iQure Pharma Inc. (iQure), a US-based global biotech company, is attending the 41st Annual J.P. Morgan Health Care Conference, JPM Week, in January 2023. iQure’s por
35
iQure Pharma is one of 25 companies invited to join the NYU Stern School of Business Endless Frontier Labs 2022-2023 cohort dedicated to companies developing treatments that address unmet health needs
21
bottom of page